Glenmark becomes the first company to launch Remogliflozin + Vildagliptin + Metformin fixed dose combination, at an affordable price for adults with Type 2 Diabetes in India
Glenmark is the first company in the world to launch Remogliflozin (100 mg) + Vildagliptin (50 mg) + Metformin (500/...
Read more
